Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BROLUCIZUMAB-DBLL: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

57.3%
Female
42.7%
Male

Age Information

The average age of patients reporting adverse events with BROLUCIZUMAB-DBLL is 76.6 years.

Geographic Distribution

The majority of adverse event reports for BROLUCIZUMAB-DBLL originate from US.

Report Summary & Outcomes

2,802
Total Reports
2,802
As Primary/Secondary Suspect
198
Deaths Reported
170
Hospitalizations
9
Life-Threatening
149
Disabilities

Reporting Timeline

First adverse event report: 20120101. Most recent report: 20250802. View full timeline →

More About BROLUCIZUMAB-DBLL

BROLUCIZUMAB-DBLL Full Profile Reports by Year Drug Interactions